MDT Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 22:00):

Stats
Dagens volum	4.39M
Gjennomsnittsvolum	6.32M
Markedsverdi	107.37B
EPS	$0 ( 2024-04-07 )
Neste inntjeningsdato	( $1.450 ) 2024-05-23
Last Dividend	$0.690 ( 2023-09-21 )
Next Dividend	$0 ( N/A )
P/E	25.67
ATR14	$0.0370 (0.05%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Marinaro Michael	Sell	854	Ordinary Shares
2024-03-05	Marinaro Michael	Sell	563	Ordinary Shares
2024-02-21	Salmon Sean	Buy	16 035	Ordinary Shares
2024-02-21	Salmon Sean	Sell	1 594	Ordinary Shares
2024-02-21	Salmon Sean	Sell	13 066	Ordinary Shares

INSIDER POWER
65.37
Last 100 transactions
Buy: 1 272 294 \| Sell: 350 051

Volum Korrelasjon

Lang: 0.43 (neutral)

Kort: 0.92 (very strong)

Signal:(70.877) Expect same movement, but be aware

Medtronic PLC Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Medtronic PLC Korrelasjon - Valuta/Råvare

0.51
( weak )

0.60
( weak )

0.00
( neutral )

0.69
( moderate )

-0.82
( strong negative )

-0.30
( neutral )

Medtronic PLC Økonomi

Annual	2023
Omsetning:	$31.23B
Bruttogevinst:	$20.51B (65.67 %)
EPS:	$2.85

FY	2023
Omsetning:	$31.23B
Bruttogevinst:	$20.51B (65.67 %)
EPS:	$2.85

FY	2023
Omsetning:	$31.23B
Bruttogevinst:	$20.51B (65.67 %)
EPS:	$2.83

FY	2022
Omsetning:	$31.69B
Bruttogevinst:	$21.54B (67.98 %)
EPS:	$3.75

Financial Reports:

No articles found.

Medtronic PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.680 (N/A)	$0.680 (N/A)	$0.680 (N/A)	$0.690 (N/A)	$0.690 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Medtronic PLC Dividend Information - Dividend King

Dividend Sustainability Score: 9.19 - good (91.95%) | Divividend Growth Potential Score: 3.67 - Decrease likely (26.69%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00219	1982-01-04
Last Dividend	$0.690	2023-09-21
Next Dividend	$0	N/A
Payout Date	2023-10-13
Next Payout Date	N/A
# dividends	167	--
Total Paid Out	$27.99	--
Avg. Dividend % Per Year	1.62%	--
Score	5.08	--
Div. Sustainability Score	9.19
Div.Growth Potential Score	3.67
Div. Directional Score	6.43	--

Next Divdend (Est)
(2024-07-31)

$0.698 Estimate 21.86 %

Dividend Stability

0.58 Average

Dividend Score

5.08

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1982	$0.00938	1.55%
1983	$0.0106	1.26%
1984	$0.0116	1.72%
1985	$0.0122	2.89%
1986	$0.0131	1.94%
1987	$0.0150	1.24%
1988	$0.0134	0.90%
1989	$0.0203	1.67%
1990	$0.0238	1.16%
1991	$0.0286	1.09%
1992	$0.0325	0.56%
1993	$0.0387	0.65%
1994	$0.0595	1.15%
1995	$0.0454	0.68%
1996	$0.0802	0.62%
1997	$0.103	0.61%
1998	$0.120	0.48%
1999	$0.145	0.40%
2000	$0.181	0.53%
2001	$0.215	0.36%
2002	$0.299	0.60%
2003	$0.280	0.60%
2004	$0.243	0.50%
2005	$0.362	0.73%
2006	$0.413	0.71%
2007	$0.470	0.89%
2008	$0.813	1.64%
2009	$0.598	1.83%
2010	$0.860	1.96%
2011	$0.936	2.50%
2012	$1.266	3.27%
2013	$1.100	2.63%
2014	$1.195	2.09%
2015	$1.445	2.01%
2016	$1.670	2.20%
2017	$1.810	2.56%
2018	$1.460	1.78%
2019	$2.12	2.41%
2020	$2.28	1.99%
2021	$2.47	2.13%
2022	$2.67	2.52%
2023	$2.06	2.63%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.130	1.500	7.40	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0462	1.200	8.46	10.00	[0 - 0.3]
returnOnEquityTTM	0.0816	1.500	-0.204	-0.307	[0.1 - 1]
payoutRatioTTM	0.871	-1.000	1.293	-1.293	[0 - 1]
currentRatioTTM	2.30	0.800	3.51	2.80	[1 - 3]
quickRatioTTM	1.459	0.800	6.12	4.90	[0.8 - 2.5]
cashRatioTTM	0.166	1.500	-0.190	-0.286	[0.2 - 2]
debtRatioTTM	0.277	-1.500	5.39	-8.08	[0 - 0.6]
interestCoverageTTM	8.05	1.000	8.13	8.13	[3 - 30]
operatingCashFlowPerShareTTM	4.87	2.00	8.38	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.71	2.00	8.15	10.00	[0 - 20]
debtEquityRatioTTM	0.485	-1.500	8.06	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.655	1.000	2.42	2.42	[0.2 - 0.8]
operatingProfitMarginTTM	0.175	1.000	8.50	8.50	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.258	1.000	9.68	9.68	[0.2 - 2]
assetTurnoverTTM	0.356	0.800	-0.961	-0.769	[0.5 - 2]
Total Score				9.19

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	25.24	1.000	7.55	0	[1 - 100]
returnOnEquityTTM	0.0816	2.50	-0.131	-0.307	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.71	2.00	8.76	10.00	[0 - 30]
dividendYielPercentageTTM	3.46	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.87	2.00	8.38	10.00	[0 - 30]
payoutRatioTTM	0.871	1.500	1.293	-1.293	[0 - 1]
pegRatioTTM	-1.029	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.200	1.000	7.50	0	[0.1 - 0.5]
Total Score				3.67

Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.